COVID-19 second wave | Pressure mounts on Biden administration to ship COVID-19 vaccines, medical supplies to India

US State Department said that the United States continues to work closely with India to facilitate the movement of essential supplies and also address the bottlenecks of the supply chains.

PTI
April 24, 2021 / 09:09 AM IST

US President Joe Biden (Image: Reuters)

The Biden administration has came under intense pressure from various quarters, including the powerful US Chambers of Commerce, lawmakers and eminent Indian-Americans, to ship AstraZeneca and other COVID-19 vaccines along with several life-saving medical supplies to India, which is witnessing a deadly surge in coronavirus cases.

"As the COVID-19 pandemic inflicts a heavy toll on countries around the globe, the U.S. Chamber strongly encourages the administration to release the millions of AstraZeneca vaccine doses in storage - as well as other life-saving support - for shipment to India, Brazil, and other nations hard-hit by the pandemic," said Myron Brilliante, executive vice president and head of international affairs at the US Chamber of Commerce.

He said these vaccine doses will not be needed in the United States, where it's estimated that vaccine manufacturers will be able to produce enough doses by early June to inoculate every American.

Follow our LIVE blog for the latest updates of the coronavirus pandemic

"This move would affirm US leadership, including in initiatives such as COVAX, and as we work with partners around the globe because no one is safe from the pandemic until we are all safe from it," Brilliante said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The US Chambers issued the statement after Indian External Affairs Minister S Jaishankar sought global help in fight against COVID-19. "Will strive to ensure that our supply chains are as smooth as possible in a difficult global situation. The world must support India, as India helps the world," he said in a tweet.

US State Department Deputy Spokesperson Jalina Porter told reporters that the United States continues to work closely with India to facilitate the movement of essential supplies and also address the bottlenecks of the supply chains. "The COVID-19 situation in India is a global concern," she said.

COVID-19 Vaccine Tracker: All you need to know about manufacturing and pricing

"We also continue to collaborate with our partners in India to battle this at the highest level. We know Secretary (of State, Tony) Blinken spoke to his counterpart on Tuesday and we remain deeply engaged with India at all levels as we work to combat this crisis of the pandemic together," Porter said.

Congresswoman Rashida Talib tweeted that the COVID-19 crisis in India is a harsh reminder that the pandemic is not over until the whole world is safe.

President Biden must support a patent waiver to ramp up global production now, she said.

"As we look to our Indian friends battling this pandemic, we'll also acknowledge the toll that it's taking, not only on the people of India, but as well as all throughout South Asia and, quite frankly, all over the world," Porter said.

The Washington Post in a lead editorial hoped that all of India can seize the moment and begin to reverse the course of this disaster. "India is not a faraway problem. In pandemic time and distance, every place is nearby," it said.

Major Democratic fundraiser for the Biden's presidential campaign Shekar Narasimhan urged the US President to speak to Prime Minister Narendra Modi. "We have to do something in the face of a humanitarian disaster. Every friend I know in the US with family in India reports that relatives have died or been affected," he said.

"President please speak to Prime Minister and see if we can lend 10M doses of AZ vaccine like tomorrow. We must help now!" he said.

Click here for Moneycontrol’s full coverage of the coronavirus pandemic
PTI
TAGS: #coronavirus #Covid-19 #Current Affairs #India #United States #vaccine
first published: Apr 24, 2021 09:09 am